Danish Ship Finance’s loan book decreased in 2024 after clients continued to prepay loans. The loan portfolio fell to DKK ...

Despite the continued success of GLP-1 drugs Ozempic and Wegovy, Novo Nordisk CEO Lars Fruergaard Jørgensen took a slight pay cut in 2024. He received 57.1 million Danish kroner (DKK) – $8 million – ...

Berenberg lowered the firm’s price target on Zealand Pharma (ZLDPF) to DKK 1,050 from DKK 1,080 and keeps a Buy rating on the shares.Discover ...

The Danish government has announced an aid package worth 2bn Danish kroner (approx. €268m) for Ukraine. Source: European ...

Denmark has pledged to donate 405 million Danish kroner (54 million euros - 56,6 million dollar) to Ukraine for its ...

Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical ...

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk's weight-loss medications Wegovy and Ozempic has been resolved, according to its website. The FDA announcement confirms ...

RBC Capital analyst Alexander Wheeler lowered the firm’s price target on Orsted (DNNGY) to DKK 370 from DKK 400.Discover the Best Stocks and ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Delivering Bakkafrost’s results for the closing period of 2024, CEO Regin Jacobsen confirmed that SCT is set for further ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...